Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
Do you favor peritoneal dialysis over hemodialysis in patients with an LVAD who have ESKD?
Related Questions
What is your approach to intensifying the hemodialysis prescription for patients found to have dialysis-related amyloidosis?
Would you opt to start IV iron load, maintenance iron therapy, or no iron at all in a patient with ESKD on hemodialysis who has a stable hemoglobin level at around 12.0 g/dL but also has low iron stores as evidenced by a low transferrin saturation and ferritin?
Do you prefer maximizing fluid removal during dialysis or starting new antihypertensive medications for patients with ESKD on intermittent hemodialysis who are chronically hypertensive?
How do you modify your peritonitis prevention strategy for a patient starting peritoneal dialysis who has a history of recurrent staphylococcal skin infections?
Would you recommend immediately exchanging a peritoneal dialysis catheter, or waiting until the completion of antibiotics with transition to HD, if a PD patient presents with peritonitis and a nonfunctional PD catheter?
Do you recommend avoiding ESAs in ESKD patients with heart failure who require a left ventricular assist device?
What is your approach to using intraperitoneal sodium thiosulfate for a patient with ESKD on peritoneal dialysis who develops calciphylaxis?
Do you avoid peritoneal dialysis in cirrhotic patients with ascites?
What degree of prolactin elevation is typically seen in patients with end stage kidney disease on hemodialysis?
How do you use NT-proBNP in patients with chronic kidney disease or end-stage kidney disease, given that these conditions can affect NT-proBNP levels?
